Recent efforts to understand the genetics of GBM have improved our knowledge of the molecular events leading to gliomagenesis and mutations; amplifications or deletions of genes such as IDH1, NF1, PTEN, P53, RB1, PDGFRA or EGFR have been identified [2,3]. This evidence concerns the gene IDH1 and glioblastoma.